Pursuant to a resolution passed by shareholders on June 16, 2014, the company has consolidated its capital on a 1:10 new basis. The name of the company has not been changed.

Effective at the opening on Monday, March 2, 2015, the common shares of Angel Bioventures Inc. will commence trading on the TSX Venture Exchange on a consolidated basis. The company is temporarily unclassified and is an NEX issuer.

Postconsolidation

Capitalization:  unlimited shares with no par value of which 1,188,852 shares are issued and outstanding

Escrow:  nil

Transfer agent:  TMX Equity Transfer Services

Trading symbol:  DDD.H (unchanged)

Cusip No.:  03463H205 (new)